Effect of rhIL-11 in Patients With Thrombocytopenia for Childhood ALL

Summary

The goal of this clinical research study is to find out if rhIL-11（Interleukin 11） may increase the platelet count in Childhood patients with acute lymphocytic leukemia (ALL) who develop low platelet counts while receiving standard CAT（cyclophosphamide+Cytosine arabinoside+mercaptopurine，7d） therapy.

Timeline

Start

2011-09

Primary completion

2014-04

Completion

2014-04

Drugs

Indications